Treatments & Interventions
Clinical Trials
Recent Trials
Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia
Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)
Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 110004001
- UMLS CUI
- C0023487
- Fully Specified Name
- Acute promyelocytic leukemia, FAB M3 (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 2
- Known Treatments
- 3
- Clinical Trials
- 5
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.